Latest IMNM reports update at 2024-03-28: 20232022
Immunome logo
Immunome IMNM
$ 15.48 -1.4%

Immunome Financial Statements 2011-2024 | IMNM

Annual Financial Statements Immunome

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

490 M 62.3 M 150 M 146 M - - - - - - - - -

Shares

19.8 M 12.1 M 11.5 M 10 M - - - - - - - - -

Historical Prices

24.7 5.14 13 9.68 - - - - - - - - -

Net Income

-107 M -36.9 M -24.7 M -17.8 M -10.4 M -7.84 M - - - - - - -

Revenue

14 M - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-110 M -36.9 M -25.2 M -12.3 M -10.3 M - - - - - - - -

Interest Expense

2.72 M 5 K 493 K -5.58 M -96 K - - - - - - - -

EBITDA

-109 M -36.5 M -24.4 M -11.5 M -9.73 M -7.22 M - - - - - - -

Operating Expenses

124 M 36.9 M 25.2 M 12.3 M 10.3 M 7.74 M - - - - - - -

General and Administrative Expenses

19.7 M 13.6 M 11.1 M 4.78 M 1.52 M 866 K - - - - - - -

All numbers in USD currency

Quarterly Income Statement Immunome

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

12.2 M 12.2 M 12.2 M 12.1 M 12.1 M 12.1 M 12.1 M 12.1 M 11.9 M 11.5 M 10.6 M 10.6 M 1.11 M 1.1 M 1.1 M 1.1 M 1.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-4.34 M -5.56 M -4.27 M - -8.53 M -8.92 M -11.7 M - -7.72 M -5.24 M -3.9 M - -8.38 M -2.71 M -2.68 M - -2.74 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

3.56 M 4.26 M 2.36 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-4.63 M -5.77 M -4.47 M - -8.53 M -8.93 M -11.7 M - -7.72 M -5.74 M -3.9 M - -2.82 M -2.72 M -2.66 M - -2.72 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

288 K 216 K 201 K - 1 K 2 K 1 K - -3 K -1 K -1 K - -10 K 5 K -22 K - -17 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -4.38 M - -8.21 M -8.93 M -11.5 M - -7.09 M -5.74 M -3.72 M - -2.32 M -2.39 M -2.49 M - -2.27 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

8.2 M 10 M 6.84 M - 8.53 M 8.93 M 11.7 M - 7.72 M 5.74 M 3.9 M - 2.82 M 2.72 M 2.66 M - 2.72 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

4.38 M 4.32 M 2.92 M - 3.31 M 3.21 M 3.58 M - 3.21 M 2.51 M 1.92 M - 1.17 M 823 K 540 K - 486 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency